Barrett's Esophagus
NSAIDs modulate biomarker panel for esophageal adenocarcinoma
Published in Drug Week, March 16th, 2007
Genetic abnormalities are common in many human cancers and their precursors, including esophageal adenocarcinoma and Barrett’s esophagus. Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed as possible chemoprevention against esophageal adenocarcinoma and Barrett’s esophagus.
A study of 243 patients with Barrett’s esophagus followed up for 10 years by Patricia Galipeau and colleagues from the Fred Hutchinson Cancer Research Center, Seattle looked at various genetic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-03-16)
More Articles from Drug Week
- Addiction Medicine
Antidepressants help men decrease alcohol consumption, but not women - Cataracts
AAO Reminds Patients Taking Prostate Meds to Inform Doctor before Cataract Surgery - Collaborations
Takeda and Tap to promote Sucampo's Amitiza in the United States - Drug Development
Manchester physicists pioneer new super-thin technology - Drug Development
Study of atomic movement may influence design of pharmaceuticals - Nanotechnology
A. James Clark School of Engineering shows in vivo "nanofactories" can make and deliver targeted drugs - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
